SALE EXTENDED
MarketBeat All Access
Start your 30-day free trial,
then continue your subscription for 50% off.
TODAY ONLY!
Claim Your Discount
×
S&P 500   3,679.35 (-1.74%)
DOW   29,539.03 (-1.30%)
QQQ   272.16 (-2.72%)
AAPL   141.18 (-2.92%)
MSFT   235.75 (-4.47%)
META   135.36 (-2.67%)
GOOGL   99.47 (-1.92%)
AMZN   116.06 (-3.52%)
TSLA   228.81 (-3.91%)
NVDA   124.84 (-4.92%)
NIO   13.85 (-6.23%)
BABA   82.14 (-2.59%)
AMD   61.96 (-8.68%)
T   15.06 (-1.70%)
MU   53.18 (-2.64%)
CGC   3.18 (-15.20%)
F   12.18 (-1.46%)
GE   64.97 (-1.89%)
DIS   97.63 (-2.41%)
AMC   6.75 (-5.20%)
PYPL   91.87 (-2.70%)
PFE   42.48 (-1.42%)
NFLX   232.55 (-3.11%)
S&P 500   3,679.35 (-1.74%)
DOW   29,539.03 (-1.30%)
QQQ   272.16 (-2.72%)
AAPL   141.18 (-2.92%)
MSFT   235.75 (-4.47%)
META   135.36 (-2.67%)
GOOGL   99.47 (-1.92%)
AMZN   116.06 (-3.52%)
TSLA   228.81 (-3.91%)
NVDA   124.84 (-4.92%)
NIO   13.85 (-6.23%)
BABA   82.14 (-2.59%)
AMD   61.96 (-8.68%)
T   15.06 (-1.70%)
MU   53.18 (-2.64%)
CGC   3.18 (-15.20%)
F   12.18 (-1.46%)
GE   64.97 (-1.89%)
DIS   97.63 (-2.41%)
AMC   6.75 (-5.20%)
PYPL   91.87 (-2.70%)
PFE   42.48 (-1.42%)
NFLX   232.55 (-3.11%)
S&P 500   3,679.35 (-1.74%)
DOW   29,539.03 (-1.30%)
QQQ   272.16 (-2.72%)
AAPL   141.18 (-2.92%)
MSFT   235.75 (-4.47%)
META   135.36 (-2.67%)
GOOGL   99.47 (-1.92%)
AMZN   116.06 (-3.52%)
TSLA   228.81 (-3.91%)
NVDA   124.84 (-4.92%)
NIO   13.85 (-6.23%)
BABA   82.14 (-2.59%)
AMD   61.96 (-8.68%)
T   15.06 (-1.70%)
MU   53.18 (-2.64%)
CGC   3.18 (-15.20%)
F   12.18 (-1.46%)
GE   64.97 (-1.89%)
DIS   97.63 (-2.41%)
AMC   6.75 (-5.20%)
PYPL   91.87 (-2.70%)
PFE   42.48 (-1.42%)
NFLX   232.55 (-3.11%)
S&P 500   3,679.35 (-1.74%)
DOW   29,539.03 (-1.30%)
QQQ   272.16 (-2.72%)
AAPL   141.18 (-2.92%)
MSFT   235.75 (-4.47%)
META   135.36 (-2.67%)
GOOGL   99.47 (-1.92%)
AMZN   116.06 (-3.52%)
TSLA   228.81 (-3.91%)
NVDA   124.84 (-4.92%)
NIO   13.85 (-6.23%)
BABA   82.14 (-2.59%)
AMD   61.96 (-8.68%)
T   15.06 (-1.70%)
MU   53.18 (-2.64%)
CGC   3.18 (-15.20%)
F   12.18 (-1.46%)
GE   64.97 (-1.89%)
DIS   97.63 (-2.41%)
AMC   6.75 (-5.20%)
PYPL   91.87 (-2.70%)
PFE   42.48 (-1.42%)
NFLX   232.55 (-3.11%)
CVE:IPA

ImmunoPrecise Antibodies - IPA Stock Forecast, Price & News

C$6.50
-0.20 (-2.99%)
(As of 10/6/2022 02:38 PM ET)
Add
Compare
Today's Range
C$6.50
C$6.95
50-Day Range
C$5.19
C$8.21
52-Week Range
C$4.52
C$8.81
Volume
9,972 shs
Average Volume
19,960 shs
Market Capitalization
C$161.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About ImmunoPrecise Antibodies

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.

Receive IPA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter.

IPA Stock News Headlines

ImmunoPrecise Antibodies reports Q3 results
ImmunoPrecise Antibodies to Begin Trading on Nasdaq Stock Exchange
IPA furthers on home SARS-CoV-2 diagnostic test
ImmunoPrecise to Present at the Virtual Gravitas Healthcare Investor Day
Stocks in play: Innunoprecise Antibodies Ltd.
ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre-Clinical Trials
See More Headlines
Receive IPA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter.

IPA Company Calendar

Last Earnings
7/29/2022
Today
10/07/2022
Next Earnings (Estimated)
12/12/2022

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
73
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$19.47 million
Cash Flow
C$0.97 per share
Book Value
C$2.67 per share

Miscellaneous

Free Float
N/A
Market Cap
C$161.44 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Jennifer Lynne Bath Ph.D.
    CEO, Pres & Non-Independent Director
  • Mr. Brad McConn
    Chief Financial Officer
  • Mr. David E. Orton
    Chief Operating Officer
  • Dr. Ilse Roodink
    Chief Scientific Officer
  • Ms. Carla Dahl
    VP of Marketing
  • Dr. Barry Neil Duplantis
    VP of Client Relations













IPA Stock - Frequently Asked Questions

How have IPA shares performed in 2022?

ImmunoPrecise Antibodies' stock was trading at C$6.89 at the start of the year. Since then, IPA shares have decreased by 5.7% and is now trading at C$6.50.
View the best growth stocks for 2022 here
.

When is ImmunoPrecise Antibodies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, December 12th 2022.
View our IPA earnings forecast
.

How were ImmunoPrecise Antibodies' earnings last quarter?

ImmunoPrecise Antibodies Ltd. (CVE:IPA) issued its quarterly earnings data on Friday, July, 29th. The company reported ($0.22) EPS for the quarter. The firm had revenue of $5.24 million for the quarter.

What other stocks do shareholders of ImmunoPrecise Antibodies own?
What is ImmunoPrecise Antibodies' stock symbol?

ImmunoPrecise Antibodies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IPA."

How do I buy shares of ImmunoPrecise Antibodies?

Shares of IPA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is ImmunoPrecise Antibodies' stock price today?

One share of IPA stock can currently be purchased for approximately C$6.50.

How much money does ImmunoPrecise Antibodies make?

ImmunoPrecise Antibodies (CVE:IPA) has a market capitalization of C$161.44 million and generates C$19.47 million in revenue each year.

How can I contact ImmunoPrecise Antibodies?

ImmunoPrecise Antibodies' mailing address is 880-580 Hornby St, VANCOUVER, BC V6C 3B6, Canada. The official website for the company is immunoprecise.com. The company can be reached via phone at +1-604-8060626.

This page (CVE:IPA) was last updated on 10/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.